Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2021 07:54 ET | Source: LAVA Therapeutics BV

LAVA Therapeutics Appoints Karen J. Wilson to its Board of Directors

UTRECHT, The Netherlands and PHILADELPHIA, April 01, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in bispecific...
March 25, 2021 03:12 ET | Source: LAVA Therapeutics BV

LAVA Therapeutics宣布首次公开发行股价

荷兰乌得勒支和美国费城, March 25, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics B.V.（纳斯达克股票代码：LVTX），一家专注于使用其在双特异性gamma-delta T细胞衔接蛋白抗体构建体方面的专业知识来转变癌症疗法的生物科技公司，今天宣布其首次公开发行的6,7000,000股普通股定价为每股15美元。此外，LAVA...
March 24, 2021 20:55 ET | Source: LAVA Therapeutics BV

LAVA Therapeutics Announces Pricing of Initial Public Offering

UTRECHT, The Netherlands and PHILADELPHIA, March 24, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics B.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in bispecific...